Market Place
Sourcing Support
Novo Nordisk to seek approval soon to sell Wegovy pill in China
17 Jun 2026 //
REUTERS
Race to Launch Weight-Loss Pill Heats up as Novo wins UK approval
13 Jun 2026 //
REUTERS
ADA: Novo`s Lange Says Jury`s Out on CagriSema vs Retatrutide
10 Jun 2026 //
FIERCE BIOTECH
Hetero, Richter Partner to Develop, Market Semaglutide
10 Jun 2026 //
ECONOMICTIMES
Biomed Industries Presents NA-931 Phase 3 Data at ADA 2026
10 Jun 2026 //
FIRSTWORD PHARMA
India`s GLP-1 Market Cools After Initial Semaglutide Surge
08 Jun 2026 //
BUSINESS STD
ADA: Novo`s Oral Wegovy Hits 3 Million Prescriptions Milestone
08 Jun 2026 //
FIERCE PHARMA
Novo Nordisk Targets 2030 Launch for Triple-G Obesity Shot
08 Jun 2026 //
ENDPOINTS
GLP-1 Drugs Tied to Lower Substance Use Disorders: UTEP Study
08 Jun 2026 //
PRESS RELEASE
Lilly`s Oral GLP-1 Foundayo Excels in Three Phase 3 Trials
08 Jun 2026 //
PR NEWSWIRE
Wegovy Pill Surpasses 3M Prescriptions as Novo Presents ADA Data
07 Jun 2026 //
PR NEWSWIRE
Once-Weekly CagriSema More Effective than Standalone Medications
07 Jun 2026 //
PR NEWSWIRE
Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide
07 Jun 2026 //
PR NEWSWIRE
Novo`s CagriSema Cuts HbA1c and Weight in REIMAGINE at ADA
07 Jun 2026 //
PR NEWSWIRE
Semaglutide 2mg Rivals Tirzepatide in HbA1c & Weight Loss in T2D
06 Jun 2026 //
PR NEWSWIRE
Novo Nordisk to Present Wegovy® Cardiometabolic Data at ADA 2026
06 Jun 2026 //
PR NEWSWIRE
Genohope Semaglutide Injection Line Gains EU GMP Certification
05 Jun 2026 //
PRESS RELEASE
Semaglutide Linked to Better Quality of Life in CKD: FLOW Trial
04 Jun 2026 //
PR NEWSWIRE
Delhi HC Directs CDSCO on Zydus Semaglutide Safety Concerns
04 Jun 2026 //
ECONOMICTIMES
Biomea Partners with Leicester to Study Icovamenib in Obesity
03 Jun 2026 //
GLOBENEWSWIRE
Wegovy Pill Launches in UAE as Novo Expands Obesity Access
03 Jun 2026 //
GLOBENEWSWIRE
Alkem Launches Semaglutide Pre-Filled Syringes in India
03 Jun 2026 //
EXPRESSPHARMA
Alkem Launches Single-Shot Semaglutide Syringe at Rs. 350
03 Jun 2026 //
INDPHARMAPOST
Mapi Pharma Joins ASCO Annual Meeting And ADA 2026 Sessions
01 Jun 2026 //
GLOBENEWSWIRE
Felix Offers Ozempic at Generic-Level Pricing in Canada
28 May 2026 //
GLOBENEWSWIRE
Lilly to Present Foundayo, Mounjaro Data at ADA 2026
28 May 2026 //
PR NEWSWIRE
Ondra Health Launches Nationwide GLP-1 Weight Loss Platform
27 May 2026 //
BUSINESSWIRE
Ozari Health Releases New Industry Research on GLP-1 Pricing
26 May 2026 //
GLOBENEWSWIRE
Brazil Approves First Generic Version of Ozempic
26 May 2026 //
REUTERS
Navigating Legal and Regulatory Landscape of GLP-1 Drugs in India
25 May 2026 //
EXPRESSPHARMA
CHMP Backs Oral Semaglutide as Most Efficacious GLP-1 Pill
22 May 2026 //
GLOBENEWSWIRE
CHMP Backs Wegovy 7.2 mg for Up to 20.7% Weight Loss
22 May 2026 //
GLOBENEWSWIRE
Hims & Hers Launches Generic Semaglutide in Canada
21 May 2026 //
BUSINESSWIRE
MedExpress Canada Launches Generic Semaglutide At $124.99
21 May 2026 //
FIRSTWORD PHARMA
Shaily Launches Combo Product with ShailyPen Neo Technology
21 May 2026 //
EXPRESSPHARMA
OTC Phentermine Alternatives 2026: PhenQ Assessed via SCALE-9
20 May 2026 //
GLOBENEWSWIRE
Phoenix, Raven 1st Canada Telehealth to Offer Generic Semaglutide
20 May 2026 //
BUSINESSWIRE
FDA Issues Warning Letter Over Chinese Supplier`s GLP-1 Import
20 May 2026 //
BIOSPACE
Dr Reddy`s launches oral semaglutide biosimilar Obeda in India
20 May 2026 //
ECONOMICTIMES
Ozari Health Launches Telehealth for Semaglutide from $86/Month
19 May 2026 //
GLOBENEWSWIRE
BioNxt Advances Semaglutide ODF into Active Pharma Development
19 May 2026 //
PHARMIWEB
Novo Nordisk to Unveil Semaglutide Data on Liver Disease
19 May 2026 //
GLOBENEWSWIRE
Caliway: CBL-514 Preclinical Data Presented at ECO 2026
19 May 2026 //
PR NEWSWIRE
India’s Counterfeit Drug Crisis & Role of AI
18 May 2026 //
EXPRESSPHARMA
Apotex Launches Generic Semaglutide Injection in Canada
14 May 2026 //
PRESS RELEASE
Semaglutide Price Drop Expected Amid Generic Expansion In India
14 May 2026 //
ECONOMICTIMES
Veru Unveils Q2 2026 Financials, Advances PLATEAU Trial Phase 2B
13 May 2026 //
GLOBENEWSWIRE
Novo Nordisk Data Shows Wegovy Pill Achieves 21.6% Weight Loss
13 May 2026 //
GLOBENEWSWIRE
Generic Entry Sparks GLP-1 Boom in India
13 May 2026 //
PHARMABIZ
Novo Nordisk: Wegovy Shows 28% Weight Loss in Early Responders
12 May 2026 //
GLOBENEWSWIRE
Lilly`s Foundayo & Low-Dose Zepbound Help Maintain Weight Loss
12 May 2026 //
PR NEWSWIRE
Semaglutide Race: Torrent Grabs 38% Market Share
08 May 2026 //
ECONOMICTIMES
Novi GLP-1 Weight Loss Options Evaluated With Dedicated Doctors
07 May 2026 //
GLOBENEWSWIRE
Medicare Expands Wegovy Access for Obesity From July 2026
07 May 2026 //
PR NEWSWIRE
Amazon Adds Ozempic Pill To Same-Day Prescription Drug Kiosks
07 May 2026 //
ENDPOINTS
Hepta Reveals Blood-Based Epigenetic Signatures of GLP-1 Response
05 May 2026 //
PHARMIWEB
Onesource Supports Second Generic Semaglutide Approval In Canada
05 May 2026 //
EXPRESSPHARMA
OneSource Partners Win Health Canada Nod for Generic Semaglutide
04 May 2026 //
INDPHARMAPOST
Ozempic Maker To Pilot Diabetes, Obesity Treatments In Singapore
03 May 2026 //
FIRSTWORD PHARMA
Affordable Semaglutide & Tirzepatide GLP-1 Program Assessed
01 May 2026 //
GLOBENEWSWIRE
